About Synnat Pharma
Synnat Pharma is a Healthcare company based in Visakhapatnam (India) founded in 2011. It manufactures active pharmaceutical ingredients and intermediates for global markets. It operates on a B2B model. The company has 189 employees. Its chief executive, as recorded, is Ritesh Karnani. Its Indian entity Synnat Pharma Private Limited reported revenue of ₹71.34 Cr. Synnat Pharma offers products and services including Active Pharmaceutical Ingredients, Intermediates, and Products Under Development. Its focus areas include Pharmaceuticals, Chemical Intermediates, Drug Precursors and API Manufacturing.
Company details
Synnat Pharma is a pharmaceutical company focused on producing active pharmaceutical ingredients and intermediates. It operates advanced manufacturing facilities in Visakhapatnam, India, with reactors ranging from 100 to 8000 liters. The company serves semi-regulated and non-regulated markets, emphasizing quality control and global supply. It also develops new products and maintains a professional team for operations.
- Headquarters Visakhapatnam, India
- Employees 189
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website synnatpharma.com
- Social LinkedIn
- Legal Name Synnat Pharma Private Limited
- Date of Incorporation 31 May, 2011
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹71.34 Cr
FY 2024 · +12% YoY
- Net Profit₹14.85 Cr
FY 2024 · 21% margin
- EBITDA₹23.61 Cr
FY 2024 · 33% margin
- Employee Count189
Associated legal entities of Synnat Pharma
Synnat Pharma operates through Synnat Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Synnat Pharma Private Limited CIN U24232TG2011PTC074746 | Active | 31 May 2011 | Hyderabad, Telangana | ₹71.3 Cr | 189 | 3 | View details |
Products & Services of Synnat Pharma
Synnat Pharma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Intermediates, and Products Under Development.
Produces essential components for pharmaceutical drugs worldwide.
Manufactures precursors used in drug development processes.
Develops new pharmaceutical compounds for future markets.
Board of directors of Synnat Pharma Private Limited (Synnat Pharma)
Synnat Pharma Private Limited is the primary company behind Synnat Pharma. The board of Synnat Pharma Private Limited currently have 3 directors; the longest-serving is Ramesh Kumar Karnani, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ramesh Kumar Karnani DIN 01679044 | Director | 31 May 2011 | 15 yrs 4 mo | Synnat Pharma Private Limited |
| Siddharth Karnani DIN 07623751 | Director | 03 Dec 2022 | 3 yrs 10 mo | Synnat Pharma Private Limited |
| Karnani Ritesh DIN 03178335 | Director | 03 Dec 2022 | 3 yrs 10 mo | Synnat Pharma Private Limited |
People of Synnat Pharma
1 people are tracked at Synnat Pharma (1 in leadership); the tracked headcount is 189.
| Name | Role | Group |
|---|---|---|
| Owner, CEO | Leadership |
Complete people profiles for Synnat Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Synnat Pharma
Figures of Synnat Pharma Private Limited, the primary company behind Synnat Pharma, for FY 2024. Revenue was ₹71.34 Cr (+12% year on year). Net profit was ₹14.85 Cr (21% margin). EBITDA was ₹23.61 Cr (33% margin). Revenue has grown at a compounded annual rate of +15% over three years and +33% over five years.
- ₹71.34 CrRevenue · FY 2024 · +12% YoY
- ₹14.85 CrNet profit · 21% margin
- ₹23.61 CrEBITDA · 33% margin
- ₹6.6 LakhPaid-up capital
- 189Employees (provident fund records)
- +15%Revenue CAGR, 3 years
- +33%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Synnat Pharma Private Limited are on its company page.
Detailed financial statements for Synnat Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synnat Pharma
Synnat Pharma was founded in 2011.
Synnat Pharma is headquartered in Visakhapatnam, India. It is registered at Visakhapatnam, Andhra Pradesh, India.
Ritesh Karnani is the CEO of Synnat Pharma, as recorded in our data.
Synnat Pharma has 189 employees.
The primary company behind Synnat Pharma, Synnat Pharma Private Limited, reported revenue of ₹71.34 Cr for FY 2024, up 12% year on year.
Synnat Pharma is a pharmaceutical company focused on producing active pharmaceutical ingredients and intermediates. It operates advanced manufacturing facilities in Visakhapatnam, India, with reactors ranging from 100 to 8000 liters. The company serves semi-regulated and non-regulated markets, emphasizing quality control and global supply. It also develops new products and maintains a professional team for operations.
Synnat Pharma offers Active Pharmaceutical Ingredients, Intermediates, and Products Under Development.
Synnat Pharma operates through Synnat Pharma Private Limited.
The legal entities of Synnat Pharma currently have 3 directors, including Siddharth Karnani, Ramesh Kumar Karnani, Karnani Ritesh.